booster
Clinical Trial – Phase 2 new covid-19 booster trial.
In the trial, vaccination with ABNCoV2 led to a substantial improvement in neutralizing antibodies against the Omicron variant.
osteoarthritis
First-in-Human – Phase 3 knee osteoarthritis trial.
The trial will evaluate the change in pain and function following subcutaneous injections of PPS versus placebo.
hepatocellular
Clinical Trial – Phase 2 hepatocellular carcinoma therapy.
The open-label trial will assess the safety and efficacy of GT90001 plus Nivolumab in patients with advanced HCC.
glioblastoma multiforme
Clinical Trial – Treatment for glioblastoma multiforme.
Assessing the overall survival is the primary endpoint of the global trial.
osteoporosis
First-in-Human – Phase 1 osteoporosis drug trial.
The trial will assess the safety, tolerability, and pharmacokinetics of TST002 to treat individuals with osteoporosis.
hypersomnia
Clinical Trial – Phase 3 idiopathic hypersomnia treatment.
The randomized, double-blind trial of Wakix will enroll nearly 200 IH patients in 60 to 80 trial sites in the US.
acute myeloid leukaemia
Clinical Trial – Acute myeloid leukemia therapy.
The company intends to commence the trial in the second half of this year.
e. coli
Clinical Trial – Phase I trial for E. Coli treatment.
The trial will analyze SNIPR001’s safety and tolerability and its effect on decreasing the colonization of E. Coli in the gut.
treatment
Clinical Trials – New diabetic foot ulcer treatment.
Cynata Therapeutics has started clinical trials with an initial cohort of patients in Adelaide of its patented product, aimed at treating diabetic foot ulcers.
latin america
Cohortias – Contract Research Organization of Latin America.
Global pharmaceutical companies have been running clinical trials in Latin America for over 20 years.
